A CXCL2 polymorphism is associated with better outcomes in patients with severe sepsis*
Authors:
- Jesús VillarJesús Villar
- Lina Pérez-MéndezLPLina Pérez-Méndez
- Carlos FloresCFCarlos Flores
- Nicole Maca-MeyerNMNicole Maca-Meyer
- Elena EspinosaEEElena Espinosa
- Arturo MurielAMArturo Muriel
- Rubén SangüesaRSRubén Sangüesa
- Jesús BlancoJBJesús Blanco
- Mercedes MurosMMMercedes Muros
- Robert M. KacmarekRKRobert M. Kacmarek
- 1 October 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 35 (10) , 2292-E1
Abstract
Several studies have implicated the CXCL2 chemokine as a mediator in the development of sepsis. We hypothesized that a tandem repeat polymorphism (AC)n in the CXCL2 gene, previously associated with susceptibility to severe sepsis, contributes to morbidity and mortality in severe sepsis. Prospective, observational, genetic study of septic patients. A network of Spanish postsurgical and critical care units. A total of 183 critically ill patients fulfilling the International Sepsis Criteria for severe sepsis. None. Patients were classified into three groups according to the presence of compound 24 ± 1 (AC) repeat genotypes: homozygote 24 ± 1 carriers (HC group), heterozygote 24 ± 1 carriers (HTC), and non 24 ± 1 carriers (NC group). Mortality, development of acute respiratory distress syndrome, and number of failing organs were determined for each group. Overall mortality was 46.4%. HC patients had a lower mortality (39.9%) than HTC (52.2%) and NC (72.7%) patients (trend test p = .018). This difference remained significant when using a multiple logistic regression analysis (p = .035). The presence of population stratification was ruled out, since 20 independent genomic control markers demonstrated homogeneity among groups. An exploratory analysis of the effect of acute respiratory distress syndrome on mortality showed a relative risk of 2.60 in the HC group (p = .0004), while in the nonhomozygote carriers (NHC) group the relative risk was 3.34 (p = .0001). Our data suggest that a tandem repeat polymorphism (AC)n at position −665 in the CXCL2 gene may be an independent predictor of mortality for severe sepsis. Additional studies are needed to confirm these results.Keywords
This publication has 37 references indexed in Scilit:
- The future of our specialty: Critical care medicine a decade from nowCritical Care Medicine, 2006
- A CXCL2 tandem repeat promoter polymorphism is associated with susceptibility to severe sepsis in the Spanish populationGenes & Immunity, 2006
- In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injuryJournal of Leukocyte Biology, 2005
- Bench-to-bedside review: Understanding genetic predisposition to sepsisCritical Care, 2004
- The Epidemiology of Sepsis in the United States from 1979 through 2000New England Journal of Medicine, 2003
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceCritical Care Medicine, 2003
- The immunopathogenesis of sepsisNature, 2002
- Septic Shock and Respiratory Failure in Community-acquired Pneumonia Have Different TNF Polymorphism AssociationsAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Multiple system organ failure in acute respiratory failureJournal of Critical Care, 1991
- Identification and characterization of macrophage inflammatory protein 2.Proceedings of the National Academy of Sciences, 1989